Diagnostic and prognostic values of critical flicker frequency determination as new diagnostic tool for objective HE evaluation in patients undergoing TIPS implantation

European Journal of Gastroenterology and Hepatology

Volumn 21, Issue 12, 2009, Pages 1383-1394

  Kircheis, Gerald ^a   Bode, Johannes G ^a   Hilger, Norbert ^b   Kramer, Thomas ^a   Schnitzler, Alfons ^a   Häussinger, Dieter ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Cirrhosis; Critical flicker frequency; Hepatic encephalopathy; Prognosis; Transjugular intrahepatic portosystemic shunt

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; SODIUM;

ADULT; ARTICLE; COGNITION; CONTROLLED STUDY; CRITICAL FLICKER FUSION; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PSYCHOMETRY; SURVIVAL RATE; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; VISUAL DISCRIMINATION;

ADULT; AGED; EPIDEMIOLOGIC METHODS; FEMALE; FLICKER FUSION; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; PROGNOSIS; PSYCHOMETRICS;

EID: 77950228969     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e328310e0c3     Document Type: Article

References (51)

1. Rössle M, Haag K, Ochs A, Sellinger M, Noldge G, Perarnau JM et al. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. W Engl J Med 1994; 330:165-1 71.
2. Rössle M, Ochs A, Gulberg V, Siegerstetter V, HoII J, Deibert P, et al. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. W Engl J Med 2000; 342:1701-1707.
3. Sanyal AJ. The use and misuse of transjugular intrahepatic portasystemic shunts. Curr Gastroenterol Rep 2000; 2:61-71.
4. Jalan R, Elton RA, Redhead DN, Finlayson ND, Hayes P. Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage. J Hepatol 1995; 23:123-128.
5. Capussotti L, Polastri R, Arico S, Carle F, Marucci MM, Corrao G. Portacaval anastomosis in patients with liver cirrhosis. Study of prognostic factors of survival by multivariate analysis. Gastroenterol Clin Biol 1992; 16: 425-429.
6. Rössle M, Siegerstetter V, Huber M, Ochs A. The first decade of the transjugular intrahepatic portosystemic shunt (TIPS): state of the art. Liver 1998; 18:73-89.
7. Ochs A, Rössle M, Haag K, Hauenstein KH, Deibert P, Siegerstetter V, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. W Engl J Med 1995; 332:1192-1197. (published erratum appears in N Engl J Med 1995; 332:1587)
8. Ferral H, Gamboa P, Postoak DW, Albernaz VS, Young CR, Speeg KV, et al. Survival after Elective Transjugular Intrahepatic Portosystemic Shunt Creation: prediction with Model for end-stage Liver Disease Score. Radiology 2004; 231:231-236.
9. Chalasani N, Clark WS, Martin LG, Kamean J, Patel NH, Boyer TD. Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shunting. Gastroenterology 2000; 118:138-144.
10. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31:864-871.
11. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001 ; 33:464-470.
12. Pomier-Layrargues G, Villeneuve JP, Deschênes M, Bui B, Perreault P, Fenyves D, et al. Transjugular intrahepatic port osystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: a randomised trial. Gut 2001 ; 48: 390-396.
13. Noite W, Wiltfang G, Schindler C, Müller H, Unterberg K, Zumhasch U, et al. Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations. Hepatology 1998; 28:1215-1225.
14. Kramer L, Bauer E, Gendo A, Funk G, Madl C, Pidlich J, et al. Neurophysiological evidence of cognitive impairment in patients without hepatic encephalopathy after transjugular intrahepatic portosystemic shunts. Am J Gastroenterol 2002; 97:162-166.
15. Deng D, Liao MS, Qin JP, Xiao-An L Relationship between pre-TIPS hepatic hemodynamics and postoperative incidence of hepatic encephalopathy. Hepatobiliary Pancreat Dis lnt 2006; 5:232-236.
16. Patel NH, Sasadeusz KJ, Seshadri R, Chalasani N, Shah H, Johnson MS, et al. Increase in hepatic arterial blood flow after TIPS creation and its potential predictive value of postprocedural encephalopathy and mortality. J Vase Interv Radiol 2001 ; 12:1279-1 284.
17. Hassoun Z, Deschênes M, Lafortune M, Dufresne MP, Perreault P, Lepanto L, et al. Relationship between pre-TIPS liver perfusion by the portal vein and the incidence of post-TIPS chronic hepatic encephalopathy. Am J Gastroenterol 2001 ; 96:1 205-1209.
18. Pomier-Layrargues G. TIPS and hepatic encephalopathy. Semin Liver Dis 1996; 16:315-320.
19. Magliocchetti N, Torchio P, Corrao G, Arico S, Favilli S. Prognostic factors for long-term survival in cirrhotic patients after the first episode of liver decompensation. Ital J Gastroenterol Hepatol 1997; 29:38-46.
20. Kircheis G, Fleig WE, Görtelmeyer R, Grafe S, Häussinger D. Assessment of low-grade hepatic encephalopathy: a critical analysis. J Hepatol 2007; 47:642-650.
21. Häussinger D, Cordoba J, Kircheis G, Vilstrup H, Fleig WE, Jones EA, et al. Definition and assessment of low-grade hepatic encephalopathy. In: Häussinger D, Kircheis G, Schliess F, editors. Hepatic encephalopathy and nitrogen metabolism. Dordrecht. The Netherlands: Springer; 2006. pp. 423-432.
22. Ferenci P, Lockwood AR, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congress of Gastroenterology, Vienna 1998. Hepatology 2002; 35:71 6-721.
23. Weissenborn K. Minimal hepatic encephalopathy: a permanent source of discussion. Hepatology 2002; 35:494-495.
24. Quero JC, Hartmann IJ, Meulstee J, Hop WC, Schalm SW. The diagnosis of subclinical encephalopathy in patients with cirrhosis using neuropsychological tests and automated electroencephalogram analysis. Hepatology 1996; 24:556-560.
25. Kircheis G, Wettstein M, Timmermann L, Schnitzler A, Häussinger D. Critical flicker frequency for quantification of low grade hepatic encephalopathy. Hepatology 2002; 35:357-366.
26. Weissenborn K, Rückert N, Hecker H, Manns MP. The number connection tests A and B: interindividual variability and use for the assessment of early hepatic encephalopathy. J Hepatol 1998; 28:646-653.
27. Conn HO. Quantifying the severity of hepatic encephalopathy. In: Conn HO, Bircher J, editors. Hepatic Encephalopathy: syndromes and therapies. East Lansing, Michigan: Medi-Ed Press; 1993. pp. 13-26.
28. Amodio P, Del Piccolo F, Marchetti P, Angelí P, lemmolo R, Caregaro L, et al. Clinical features and survivial of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests. Hepatology 1999; 29:1662-1667.
29. Quero JC, Schalm SW. Subclinical hepatic encephalopathy. Semln Liv Dis 1996; 16:321-328.
30. Groeneweg M, Moerland W, Quero JC, Hop WC, Krabbe PF, Schalm SW. Screening of subclinical hepatic encephalopathy. J Hepatol 2000; 32: 748-753.
31. Watanabe A, Tuchida T, Yata Y, Kuwabara Y. Evaluation of neuropsychological function in patients with liver cirrhosis with special reference to their driving ability. Metab Brain Dis 1995; 10:239-248.
32. Yen CL, Liaw YF. Somatosensory evoked potentials and number connection test in the detection of subclinical hepatic encephalopathy. Hepatogastroenterology 1990; 37:332-334.
33. Montoliu C, Piedrafita B, Serra MA, del Olmo JA, Ferrandez A, Rodrigo JM, et al. Activation of soluble guanylate cyclase by nitric oxide in lymphocytes correlates with minimal hepatic encephalopathy in cirrhotic patients. J Mol Med 2007; 85:233-241.
34. Sharma P, Sharma BC, Puri V, Sarin SK. Critical flicker frequency: diagnostic tool for minimal hepatic encephalopathy. J Hepatol 2007; 47:67-73.
35. Zafiris O, Kircheis G, Rood HA, Boers F, Häussinger D, Zilles K. Neural mechanism underlying impaired visual judgement in the dysmetabolic brain: an fMRI study. Neurolmage 2004; 22:541-552.
36. Miese F, Kircheis G, Wittsack HJ, Wenserski F, Hemker J, Modder U, et al. 1H-MR spectroscopy, magnetization transfer, and diffusion-weighted imaging in alcoholic and nonalcoholic patients with cirrhosis with hepatic encephalopathy. Am J Neuroradiol 2006; 27:1019-10126.
37. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60:646-649.
38. Vienna test system (WINWTS), Version 4.50, Dr. Schuhfried G., GmbH, Mödling, Austria (1999).
39. Saunders JB, Walters JR, Davies P, Paton A. A 20-year prospective study of cirrhosis. Br Med J (Clin Res Ed) 1981 ; 282:263-266.
40. Christensen E, Schlichting P, Andersen PK, Fauerholdt L, Schou G, Pedersen BV, et al. Updating prognosis and therapeutic effect evaluation in cirrhosis with Cox's multiple regression model for time-dependent variables. Scand J Gastroenterol 1986; 21:163-174.
41. Ginès P, Quintero E, Arroyo V, Teres J, Bruguera M, Rimóla A, et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology 1987; 7:122-128.
42. Christensen E, Krintel JJ, Hansen SM, Johansen JK, Juhl E. Prognosis after the first episode of gastrointestinal bleeding or coma in cirrhosis. Survival and prognostic factors. Scand J Gastroenterol 1989; 24:999-1006.
43. Bustamante J, Rimola A, Ventura PJ, Navasa M, Cirera I, Reggiardo V, et al. Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol 1999; 30:890-895.
44. Schlichting P, Christensen E, Andersen PK, Fauerholdt L, Juhl E, Poulsen H, et al. Prognostic factors in cirrhosis identified by Cox's regression model. Hepatology 1983; 3:889-895.
45. Angermayr B, Cejna M, Karnel F, Gschwantler M, Koenig F, Pidlich J, et al. Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut 2003; 52:879-885.
46. Sanyal AJ, Genning C, Reddy KR, Wong F, Kowdley KV, Benner K, et al. The North American Study for the Treatment of Refractory Ascites Group. Gastroenterology 2003; 124:634-641.
47. Gines P, Uriz J, Calahorra B, Garcia-Tsao G, Kamath PS, Del Arbol LR, et al. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology 2002; 123:1839-1847.
48. Ekindjian OG, Devanlay M, Duchassaing D, Leluan G, Kammerer J, Fouet P, etal. Multivariate analysis of clinical and biological data in cirrhotic patients: application to prognosis. Eur J Clin Invest 1981; 11:213-220.
49. Milani A, Marra L, Siciliano M, Rossi L. Prognostic significance of clinical and laboratory parameters in liver cirrhosis: a multivariate statistical approach. Hepatogastroenterology 1985; 32:270-272.
50. Adler M, Van Laethem J, Gilbert A, Gelin M, Bourgeois N, Vereerstraeten P, et al. Factors influencing survival at one year in patients with nonbiliary hepatic parenchymal cirrhosis. Dig Dis Sci 1990; 35:1-5.
51. Parsons-Smith BG, Summerskill WH, Dawson AM, Sherlock S. The electroencephalograph in liver disease. Lancet 1957; 273: 867-871.